Gene profiling reveals increased expression of uteroglobin and other anti-inflammatory genes in glucocorticoid-treated nasal polyps

Journal of Allergy and Clinical Immunology

Volumn 113, Issue 6, 2004, Pages 1137-1143

  Benson, Mikael ^a,b   Carlsson, Lena ^c   Adner, Mikael ^a   Jernås, Margareta ^c   Rudemo, Mats ^d   Sjögren, Anders ^d   Svensson, Per Arne ^c   Uddman, Rolf ^a   Olaf Cardell, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

CCL; Chemokine (C C motif) ligand; Ct; Cycle threshold; GC; Glucocorticoid; microarray; PDE; Phosphodiesterase; Polyp; uteroglobin

Indexed keywords

FLUTICASONE; FUNCTIONAL GROUP; GLOBIN; GLUCOCORTICOID; MAMMAGLOBIN B; UNCLASSIFIED DRUG; UTEROGLOBIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERMETHOD COMPARISON; MALE; NASAL BIOPSY; NOSE MUCOSA; NOSE POLYP; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STAINING; UPREGULATION;

ADULT; ANTI-INFLAMMATORY AGENTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NASAL POLYPS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; UTEROGLOBIN;

EID: 3042710946     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.02.028     Document Type: Article

References (40)

1. Mygind N., Dahl R., Bachert C. Nasal polyposis, eosinophil dominated inflammation and allergy. Thorax. 55:(suppl 2):2000;S79-S83
2. Bachert C., Gevaert P., Holtappels G., Johansson S.G., van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol. 107:2001;607-614
3. Hamilos D.L., Thawley S.E., Kramper M.A., Kamil A., Hamid Q.A. Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease. J Allergy Clin Immunol. 103:1999;79-87
4. Mastruzzo C., Greco L.R., Nakano K., Nakano A., Palermo F., Pistorio M.P., et al. Impact of intranasal budesonide on immune inflammatory responses and epithelial remodeling in chronic upper airway inflammation. J Allergy Clin Immunol. 112:2003;37-44
5. Webster J.C., Huber R.M., Hanson R.L., Collier P.M., Haws T.F., Mills J.K., et al. Dexamethasone and tumor necrosis factor-alpha act together to induce the cellular inhibitor of apoptosis-2 gene and prevent apoptosis in a variety of cell types. Endocrinology. 143:2002;3866-3874
6. Yoshida N.L., Miyashita T., Mami U., Yamada M., Reed J.C., Sugita Y., et al. Analysis of gene expression patterns during glucocorticoid-induced apoptosis using oligonucleotide arrays. Biochem Biophys Res Commun. 293:2002;1254-1261
7. Maurer M., Trajanoski Z., Frey G., Hiroi N., Galon J., Willenberg H.S., et al. Differential gene expression profile of glucocorticoids, testosterone, and dehydroepiandrosterone in human cells. Horm Metab Res. 33:2001;691-695
8. Obexer P., Certa U., Kofler R., Helmberg A. Expression profiling of glucocorticoid-treated T-ALL cell lines: rapid repression of multiple genes involved in RNA-, protein- and nucleotide synthesis. Oncogene. 19:2001;4324-4336
9. Tonko M., Ausserlechner M.J., Bernhard D., Helmberg A., Kofler R. Gene expression profiles of proliferating vs. G1/G0 arrested human leukaemia cells suggest a mechanism for glucocorticoid-induced apoptosis. FASEB J. 15:2001;693-699
10. Meagher L.C., Cousin J.M., Seckl J.R., Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol. 156:1996;4422-4428
11. Benson M., Cardell L.O., Carlsson B., Jernås M., Reinholdt J., Svensson P.A., et al. DNA microarrays to study gene expression in allergic airways. Clin Exp Allergy. 30:2002;1-8
12. Fritz S.B., Terrell J.E., Conner E.R., Kukowska-Latallo J.F., Baker J.R. Nasal mucosal gene expression in patients with allergic rhinitis with and without nasal polyps. J Allergy Clin Immunol. 112:2003;1057-1063
13. Gabrielsson B.G., Johansson J.M., Jennische E., Jernas M., Itoh Y., Peltonen M., et al. Depot-specific expression of fibroblast growth factors in human adipose tissue. Obes Res. 10:2002;608-616
14. Ohlsson B.G., Englund M.C., Karlsson A.L., Knutsen E., Erixon C., Skribeck H., et al. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages. J Clin Invest. 98:1996;78-89
15. Webster J.I., Tonelli L., Sternberg E.M. Neuroendocrine regulation of immunity. Annu Rev Immunol. 20:2002;125-126
16. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Nat Acad Sci. 98:2001;5116-5121
17. Efron B., Tibshirani R., Storey J.D., Tusher V. Empirical Bayes analysis of a microarray experiment. J Am Stat Assoc. 96:2001;1151-1160
18. Delgado M., Fernández-Alfonso S.M., Fuentes J. Effect of adrenaline and glucocorticoids on monocyte cAMP-specific phosphodiesterase (PDE4) in a monocytic cell line. Arch Dermatol Res. 4:2002;190-197
19. Sim T.C., Reece L.M., Hilsmeier K.A., Grant J.A., Alam R. Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am J Respir Crit Care Med. 152:1995;927-933
20. Benson M., Strannegård I.L., Wennergren G., Strannegård Ö. Interleukin-5 and interleukin-8 in relation to eosinophils and neutrophils in nasal fluids from school children with seasonal allergic rhinitis. Pediatr Allergy Immunol. 10:1999;178-185
21. Cancedda M.H.C., Filaci G., Puppo F., Ghio M., Contini P., Indiveri F. Immune homeostasis requires several biologic factors including glucocorticoid hormones. Ann N Y Acad Sci. 966:2002;49-63
22. Gamble E., Grootendorst D.C., Brightling C.E., Troy S., Qui Y., Zhu J., et al. Anti-inflammatory effects of the phosphodiesterase 4 inhibitor cilomilast (Ariflo) in COPD. Am J Respir Crit Care Med. 2003;. [Epub ahead of print]
23. Hale G. Alemtuzumab in stem cell transplantation. Med Oncol. 19:(suppl):2002;S33-S47
24. Terry Speed. Statistical analysis of gene expression microarray data. 2003;Chapman & Hall/CRC, New York
25. Benson M., Strannegård I.L., Wennergren G., Strannegård Ö. Cytokines in nasal fluids from school children with seasonal allergic rhinitis. Pediatr Allergy Immunol. 8:1997;143-149
26. Benson M., Strannegard I.-L., Strannegard O., Wennergren G. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils. J Allergy Clin Immunol. 106:2000;307-312
27. Schwiebert L.M., Beck L.A., Stellato C., Bickel C.A., Bochner B.S., Schleimer R.P. Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. J Allergy Clin Immunol. 97:1996;143-152
28. Ramirez F., Fowell D.J., Puklavec M., Simmonds S., Mason D. Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J Immunol. 156:1996;2406-2412
29. Robinson D., Hamid Q., Ying S., Bentley A., Assoufi B., Durham S., et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression. Am Rev Respir Dis. 148:1993;401-406
30. Henriksson G., Norlander T., Forsgren J., Stierna P. Effects of topical budesonide treatment on glucocorticoid receptor mRNA down-regulation and cytokine patterns in nasal polyps. Am J Rhinol. 15:2001;1-8
31. Singh G., Katyal S.L. Clara cell proteins. Ann N Y Acad Sci. 923:2000;43-58
32. Miele L. New weapons against inflammation: dual inhibitors of phospholipase A2 and transglutaminase. J Clin Invest. 111:2003;19-21
33. Sohn J., Kim T.I., Yoon Y.H., Kim J.Y., Kim S.Y. Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis. J Clin Invest. 111:2003;121-128
34. Berg T., Cassel T.N., Schwarze P.E., Nord M. Glucocorticoids regulate the CCSP and CYP2B1 promoters via C/EBPbeta and delta in lung cells. Biochem Biophys Res Commun. 293:2002;907-912
35. Levy D., Clish C.B., Schmidt B., Gronert K., Serhan C.N. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol. 2:2001;612-619
36. Suzuki T., Kiyokawa N., Taguchi T., Sekino T., Katagiri Y.U., Fujimoto J. CD24 induces apoptosis in human B cells via the glycolipid-enriched membranedomains/rafts-mediated signaling system. J Immunol. 166:2001;5567-5577
37. Heaney M.L., Golde D.W. Soluble receptors in human disease. J Leukoc Biol. 64:1998;135-146
38. Re F., Muzio R.M., De N., Polentarutti J.G., Giri A., Mantovani A., et al. The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J Exp Med. 179:1994;739-744
39. Daun J.M., Ball R.W., Cannon J.G. Glucocorticoid sensitivity of interleukin-1 agonist and antagonist secretion: the effects of age and gender. Am J Physiol Integr Comp Physiol. 278:2000;R855-R862
40. Lohr J., Knoechel B., Jiang S., Sharpe A.H., Abbas A.K. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nat Immunol. 4:2003;664-669